Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment.

Lazure P, Eyre TA, Niemann CU, Shah NN, Dreyling M, Cymbalista F, Peloquin S, Znamensky S, Goebel B, Murray S

Open source

DOI
10.1002/cnr2.70655
Published
2026 Aug
Container
Cancer reports (Hoboken, N.J.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cnr2.70655,
  title = {Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment.},
  author = {Lazure P and Eyre TA and Niemann CU and Shah NN and Dreyling M and Cymbalista F and Peloquin S and Znamensky S and Goebel B and Murray S},
  year = {2026},
  journal = {Cancer reports (Hoboken, N.J.)},
  doi = {10.1002/cnr2.70655},
  url = {https://doi.org/10.1002/cnr2.70655}
}

RIS

TY  - JOUR
TI  - Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment.
AU  - Lazure P
AU  - Eyre TA
AU  - Niemann CU
AU  - Shah NN
AU  - Dreyling M
AU  - Cymbalista F
AU  - Peloquin S
AU  - Znamensky S
AU  - Goebel B
AU  - Murray S
PY  - 2026
JO  - Cancer reports (Hoboken, N.J.)
DO  - 10.1002/cnr2.70655
UR  - https://doi.org/10.1002/cnr2.70655
ER  - 

APA

P, L., TA, E., CU, N., NN, S., M, D., F, C., S, P., S, Z., B, G., & S, M. (2026). Treatment, Monitoring, and Management of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Evidence From a Multi-Country Needs Assessment.. Cancer reports (Hoboken, N.J.). https://doi.org/10.1002/cnr2.70655

Source records